CLOTOL LIQ DIN 00225797
Health Canada record
| Active ingredient(s) | BUTYL ALCOHOL 7.0 %; SODIUM CHLORIDE 0.9 % |
|---|---|
| Dosage form | Liquid |
| Route | Subcutaneous; Intraperitoneal; Intravenous; Intramuscular |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1960 |
| Current status date | 30-Jul-2012 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BUTYL ALCOHOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02299674 | IMREX CLOTTING SOLUTION | IMREX INC. | Solution | BUTYL ALCOHOL 70 MG; SODIUM CHLORIDE 9 MG | Cancelled Post Market |
International API supply for BUTYL ALCOHOL
0 active FDA Drug Master Files.
Request a quote for CLOTOL LIQ